Assessing cost-effectiveness of alternative bus technologies: Evidence from US transit agencies

被引:10
|
作者
Avenali, Alessandro [1 ]
Catalano, Giuseppe [1 ]
Giagnorio, Mirko [1 ,2 ]
Matteucci, Giorgio [1 ]
机构
[1] Sapienza Univ Rome, Dept Comp Control & Management Engn, Rome, Italy
[2] Sapienza Univ Rome, Dept Mech & Aerosp Engn, Rome, Italy
关键词
Transit buses; Electric buses; Life Cycle Cost; Total Cost of Ownership; Environmental benefit; LIFE-CYCLE ASSESSMENT; ASSESSING STANDARD COSTS; HEAVY-DUTY TRUCKS; NATURAL-GAS; ELECTRIC BUS; FUEL; VEHICLES; DIESEL; EMISSIONS; TRANSPORT;
D O I
10.1016/j.trd.2023.103648
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
This paper aims to analyze overall economic and environmental performances of alternative bus powertrains by focusing on U.S. active fleets in different urban contexts. We define a life cycle cost model related to bus technologies by referring to real-world data of 256 transport operators, which provide more than 80% of total vehicle revenue miles produced by urban transit mode across the U.S. in 2019. The proposed method includes some service parameters that significantly affect the supply cost (e.g., service speed, annual mileage), on which we perform scenario and sensitivity analysis. Results show that electric buses are cost-competitive in large cities and metropolises, where urban bus routes are characterized by a high level of congestion, high service frequency, and the highest marginal impact of harmful emissions. In towns and suburban areas, where bus routes are longer and faster, full electric technology still faces both economic and technical barriers.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Assessing the cost-effectiveness of emerging therapies in the ICU
    Chalfin, DB
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 20 (03) : 263 - 270
  • [32] Assessing cost-effectiveness of drug interventions for schizophrenia
    Magnus, A
    Carr, V
    Mihalopoulos, C
    Carter, R
    Vos, T
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2005, 39 (1-2): : 44 - 54
  • [33] Digital mammography: A model for assessing cost-effectiveness
    Nields, MW
    Galaty, RR
    ACADEMIC RADIOLOGY, 1998, 5 : S310 - S313
  • [34] Assessing cost-effectiveness in the management of multiple sclerosis
    Phillips, Ceri J.
    Humphreys, Ioan
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2009, 1 : 61 - 78
  • [35] Assessing the safety and cost-effectiveness of early nanodrugs
    Vines, Timothy
    Faunce, Thomas
    JOURNAL OF LAW AND MEDICINE, 2009, 16 (05) : 822 - 845
  • [36] ASSESSING THE COST-EFFECTIVENESS OF NSAID - AN INTERNATIONAL PERSPECTIVE
    DRUMMOND, M
    FERRAZ, MB
    MASON, J
    JOURNAL OF RHEUMATOLOGY, 1995, 22 (07) : 1408 - 1411
  • [37] ASSESSING COST-EFFECTIVENESS IN ORTHOPEDIC OUTCOME STUDIES
    GILLESPIE, WJ
    DAELLENBACH, HG
    ORTHOPEDICS, 1992, 15 (11) : 1275 - 1277
  • [38] Assessing cost-effectiveness of sealant placement in children
    Quiñonez, RB
    Downs, SM
    Shugars, D
    Christensen, J
    Vann, WF
    JOURNAL OF PUBLIC HEALTH DENTISTRY, 2005, 65 (02) : 82 - 89
  • [39] Assessing the cost-effectiveness of postmastectomy radiation therapy
    Marks, LB
    Hardenbergh, PH
    Winer, ET
    Prosnitz, LR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (01): : 91 - 98
  • [40] Challenges in Assessing the Cost-effectiveness of Cancer Immunotherapy
    Green, Angela K.
    JAMA NETWORK OPEN, 2021, 4 (01)